Frontiers in Neuroscience (Jun 2014)

Opportunities and perspectives for developing orexin receptor antagonists

Michel Alexander Steiner,
Christopher J Winrow

Affiliations

Michel Alexander Steiner: Actelion Pharmaceuticals Ltd.
Christopher J Winrow: Merck Research Laboratories

DOI: https://doi.org/10.3389/fnins.2014.00158
Journal volume & issue: Vol. 8

Abstract

No abstracts available.

Published in Frontiers in Neuroscience

ISSN: 1662-4548 (Print); 1662-453X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.frontiersin.org/neuroscience

About the journal